We are using cookies to implement functions like login, shopping cart or language selection for this website. Furthermore we use Google Analytics to create anonymized statistical reports of the usage which creates Cookies too. You will find more information in our privacy policy.
OK, I agree I do not want Google Analytics-Cookies
International Poster Journal of Dentistry and Oral Medicine



Forgotten password?


Int Poster J Dent Oral Med 17 (2015), BDO,DGMKG,IFDAS     8. Oct. 2015
Int Poster J Dent Oral Med 17 (2015), BDO,DGMKG,IFDAS  (08.10.2015)

Supplement, Poster 919, Language: English

Dexmedetomidine-based intravenous sedation of a Glucose-6-phosphate dehydrogenase deficiency pediatric patient: A case report
Takahashi, Nanae / Takahashi, Masato / Matsumura, Tomoka
Aim:While the anti-oxidation and anti-inflammatory effect of dexmedetomidine has been reported, we could not find a case report in which glucose-6-dehydrogenase(G6PD) deficiency was treated with dexmedetomidine. We report a case of the superior labial frenulectomy under the intravenous sedation using fentanyl,midazoram and dexmedetomidine on a pediatric patient with G6PD deficiency.
Methods:The patient was a 5-year-old boy (height 115cm,body weight 22kg) with G6PD deficiency. He had no previous medical history of hemolytic anemia. The patient was uncooperative with regard to dental treatment. We planned to perform frenectomy under intravenous sedation. To prevent hemolysis due to stress from certain drugs, metabolic conditions, and infections are the most effective management. Therefore, we decided to perform the procedure under intravenous sedation with fentanyl (25µg), midazolam (2mg) and dexmedetomidine (0.7µg/kg/hr). We also used 2% lidocaine (with 1/80,000 epinephrine) for local anesthesia (0.9ml). Dexmedetomidine has been reported to cause less respiratory depression than the other sedatives and to be effective for pediatric sedation. 
Result: During perioperative period, we did not find any signs of hemolysis, such as fatigue, headache, and dark urine after using this method. Therefore, no hemolysis therapy was necessary. 
Conclusion:Dexmedetomidine was safe and effective for this pediatric patient with G6PD deficiency. We suggest that Dexmedetomidine will be one of the safe drugs that can be used for pediatric patient with G6PD deficiency.

Keywords: G6PD deficiency, Dexmedetomidine, sedation, pediatric patient

2nd joint Congress of DGMKG and BDO, 32nd Annual Congress of BDO & 14th International Dental Congress on Anesthesia, Sedation and Pain control of IFDAS (2015)
08.-10. October 2015
Berlin, Germany